Patients with inflammatory bowel disease on immunosuppressive drugs: perspectives' on COVID-19 and health care service during the pandemic
| Autor: | Bjørn Moum, Randi Opheim, Kristian Marling Moum |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Male
Health care service immunosuppressive drugs Disease Inflammatory bowel disease 0302 clinical medicine Crohn Disease Pandemic Outpatient clinic COVID-19/epidemiology Norway Gastroenterology Patient Preference Continuity of Patient Care/standards Continuity of Patient Care Middle Aged Ulcerative colitis Norway/epidemiology 030220 oncology & carcinogenesis 030211 gastroenterology & hepatology Female Attitude to Health Immunosuppressive Agents Adult medicine.medical_specialty Coronavirus disease 2019 (COVID-19) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Physical Distancing Patient Compliance/psychology 03 medical and health sciences Internal medicine medicine Remote Consultation/statistics & numerical data Humans health-care service business.industry SARS-CoV-2 Remote Consultation COVID-19 Communicable Disease Control/methods medicine.disease digestive system diseases Crohn Disease/drug therapy Communicable Disease Control Immunosuppressive Agents/therapeutic use Patient Compliance Colitis Ulcerative Self Report business Colitis Ulcerative/drug therapy |
| Zdroj: | Moum, K M, Moum, B & Opheim, R 2021, ' Patients with inflammatory bowel disease on immunosuppressive drugs : perspectives’ on COVID-19 and health care service during the pandemic ', Scandinavian Journal of Gastroenterology, vol. 56, no. 5, pp. 545-551 . https://doi.org/10.1080/00365521.2021.1901308 |
| ISSN: | 1502-7708 0036-5521 |
| DOI: | 10.1080/00365521.2021.1901308 |
| Popis: | Background and aims: Patients with inflammatory bowel diseases (IBD) have experienced changes to the routine management because of the SARS-CoV-2 pandemic. The aim of this study was to examine patients with IBD’s adherence to the restrictions imposed by society and the hospital, worries and concerns regarding medical treatment and clinical follow-up under the pandemic. Methods: IBD patients (≥18 years) at the outpatient clinic at Oslo University Hospital were included and answered a self-report questionnaire including concerns regarding their disease, medical therapy and follow-up during SARS-CoV-2 pandemic. Results: In total, 522 IBD patients were included, 317 Crohn’s disease, 205 ulcerative colitis, 386 patients |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|